Narkhede Akshay A, Shevde Lalita A, Rao Shreyas S
Department of Chemical and Biological Engineering, The University of Alabama, Tuscaloosa, AL.
Department of Pathology and Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, AL.
Int J Cancer. 2017 Sep 15;141(6):1091-1109. doi: 10.1002/ijc.30748. Epub 2017 May 10.
The progression of breast cancer from the primary tumor setting to the metastatic setting is the critical event defining Stage IV disease, no longer considered curable. The microenvironment at specific organ sites is known to play a key role in influencing the ultimate fate of metastatic cells; yet microenvironmental mediated-molecular mechanisms underlying organ specific metastasis in breast cancer are not well understood. This review discusses biomimetic strategies employed to recapitulate metastatic organ microenvironments, particularly, bone, liver, lung and brain to elucidate the mechanisms dictating metastatic breast cancer cell homing and colonization. These biomimetic strategies include in vitro techniques such as biomaterial-based co-culturing techniques, microfluidics, organ-mimetic chips, bioreactor technologies, and decellularized matrices as well as cutting edge in vivo techniques to better understand the interactions between metastatic breast cancer cells and the stroma at the metastatic site. The advantages and disadvantages of these systems are discussed. In addition, how creation of biomimetic models will impact breast cancer metastasis research and their broad utility is explored.
乳腺癌从原发性肿瘤发展到转移阶段是定义IV期疾病的关键事件,IV期疾病不再被认为可治愈。已知特定器官部位的微环境在影响转移细胞的最终命运方面起着关键作用;然而,乳腺癌中器官特异性转移背后的微环境介导分子机制尚未完全明确。本综述讨论了用于重现转移器官微环境的仿生策略,特别是骨、肝、肺和脑,以阐明决定转移性乳腺癌细胞归巢和定植的机制。这些仿生策略包括体外技术,如基于生物材料的共培养技术、微流控技术、器官模拟芯片、生物反应器技术和脱细胞基质,以及前沿的体内技术,以更好地理解转移性乳腺癌细胞与转移部位基质之间的相互作用。讨论了这些系统的优缺点。此外,还探讨了仿生模型的创建将如何影响乳腺癌转移研究及其广泛应用。